Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

Lisa Rice, Cristina M. Padilla, Sarah McLaughlin, +13

Journal of Clinical Investigation

A Longitudinal Biomarker for the Extent of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis

Lisa Rice, Jessica Ziemek, Eric A. Stratton, +12

Arthritis & Rheumatology

Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin

Sokratis A. Apostolidis, Giuseppina Stifano, Tracy Tabib, +4

Frontiers in Immunology

Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor

Lisa Rice, Charlotte Waters, Jennifer Eccles, +12

Journal of Endocrinology

Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis

Giuseppina Stifano, Alsya J. Affandi, Allison L. Mathes, +6

Arthritis Research & Therapy

mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease

Jingsong Cao, Minjung Choi, Eleonora Guadagnin, +37

Nature Communications

Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis

Giuseppina Stifano, Thierry Sornasse, Lisa Rice, +7

Arthritis & Rheumatology

Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90

Banafsheh Nazari, Lisa Rice, Giuseppina Stifano, +7

American Journal Of Pathology

Altered Dermal FibroblastsFibrosisSclerostinAutoimmune DiseaseSystemic Scleroderma +9

Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model

P. Duffau, Hanni Menn‐Josephy, Carla M. Cuda, +14

Arthritis & Rheumatology

Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency

Ahmad Karadagi, Alex Cavedon, Helen Zemack, +11

Scientific Reports